Brain

Front Porch announces Brain and Balance Center in Carlsbad, California

Carlsbad By The Sea senior living community develops innovative, empowering program CARLSBAD, Calif., Nov. 7, 2024 /PRNewswire/ -- Front Porch,…

1 year ago

Cryoport Reports Third Quarter 2024 Financial Results

Q3 2024 Life Sciences Services revenue up 9% year-over-year, including BioStorage/BioServices revenue up 12% year-over-year Supported a record total of…

1 year ago

Miro Named as a Leader in the 2024 IDC MarketScape for Team Collaboration Applications

SAN FRANCISCO and AMSTERDAM, Nov. 7, 2024 /PRNewswire/ -- Miro®, the Innovation Workspace, has been named as a Leader in the…

1 year ago

Harbinger Health Announces New Partnership with Leading Cancer Center to Accelerate Clinical Evidence Generation

Collaboration to include future projects developing novel tools for cancer screening and detection that leverage premier academic institution's large set…

1 year ago

Lupus Research Alliance Launches the DREAM Knowledge-Exchange Platform to Accelerate Precision Medicine in Lupus

The DREAM is the final component of the Lupus Research Alliance's Lupus Nexus, an innovative program that provides unprecedented resources…

1 year ago

REMORY: A Sea Squirt-Derived Plasmalogen Supplement Expands in the U.S. Market

REMORY: Elevate Cognitive Health with Unique Sea Squirt-Derived Plasmalogens. Now in the U.S., this Japanese-Innovated Supplement Combines EPA, DHA, and…

1 year ago

Lexaria Updates Fast-Moving GLP-1 ‘Arm’s Race’ Developments

DehydraTECH™ for GLP-1 being optimized for global pharmaceutical use KELOWNA, BC / ACCESSWIRE / November 7, 2024 / Lexaria Bioscience…

1 year ago

Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC

Partnerships will employ Vaccinex’s ActivMAb® platform for viral display of complex antigens to enable antibody discoveryROCHESTER, N.Y., Nov. 07, 2024…

1 year ago

BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING

MINNEAPOLIS, Nov. 6, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its market-leading portfolio to advance cancer…

1 year ago

Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434

– Peer-Reviewed Publication Describes How ATH434 Uniquely Targets Excess Iron –MELBOURNE, AUSTRALIA and SAN FRANCISCO, Nov. 06, 2024 (GLOBE NEWSWIRE)…

1 year ago